Latest News
Here you can find all the latest news from the MRC CTU at UCL.
NeoSep1 Part 1 study shows promising antibiotic options for newborns with suspected sepsis
New results found that off-patent antibiotics fosfomycin and flomoxef were safe in newborn babies with suspected sepsis.
Groundbreaking £50m MRC Centre will overhaul clinical trials for patients
The centre plans to shake up approaches to clinical trial design and delivery by developing pioneering new ways to speed up the process and drive improvements in treatment and recovery.
International collaboration sheds light on how aspirin prevents cancer
A research collaboration led from the MRC CTU at UCL suggests that the anti-cancer effects of aspirin are mediated through suppression of platelet activation.
UCL Joins WHO Global Clinical Trials Forum
As a new member of the WHO’s Global Clinical Trial Forum, the MRC CTU at UCL will be bringing cutting-edge trial design, conduct and analysis to strengthen research systems worldwide.
Shorter, more intensive treatment for TB meningitis in children is not as effective as the standard treatment
SURE trial results presented today at the Union conference did not show that a shorter, intensive treatment for TB meningitis in children is as good as the standard treatment. Adding aspirin also showed no benefit.